How long do new medicines take to reach Canadian patients after companies file a submission: A cohort study

Studies of the delay between when companies file a New Drug Submission (NDS) and when drugs reach Canadian patients typically focus on the time in the regulatory review process and do not analyze the time between when approval is granted and the drug is available for purchase (company decision time)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2020-11, Vol.15 (11), p.e0240966-e0240966
1. Verfasser:	Lexchin, Joel
Format:	Artikel
Sprache:	eng
Schlagworte:	Annual reports Biological products Biology and Life Sciences Canada Cohort analysis Cohort Studies Decisions Drug approval Drug Approval - legislation & jurisprudence Drug Approval - methods Drug Industry Drugs Engineering and Technology Equipment and supplies Forecasts and trends Health care industry Humans Marketing Mathematical analysis Medicine and Health Sciences Pharmaceutical industry Pharmacy Physical Sciences Production management Research and Analysis Methods Science Policy Social Sciences Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!